On February 2, 2022, President Biden announced plans to reignite the Cancer Moonshot to end cancer as we know it.
As Vice President, in 2016, Joe Biden launched the Cancer Moonshot with the mission to accelerate the rate of progress against cancer. The cancer and patient community and medical researchers responded with tremendous energy and ingenuity.
At its launch, the Cancer Moonshot set forth three ambitious goals: to accelerate scientific discovery in cancer, foster greater collaboration, and improve the sharing of data.
On February 2, 2022, President Biden announced a reignition of the Cancer Moonshot, highlighting new goals: to reduce the death rate from cancer by at least 50 percent over the next 25 years and improve the experience of people and their families living with and surviving cancer—and, by doing these and more, to end cancer as we know it today.
By focusing on areas of cancer research that are most likely to benefit patients as a result of new investment, the Cancer Moonshot has brought together a large community of investigators and clinicians who are dedicated to expediting research to improve the lives of people with cancer and their loved ones.
Congress passed the 21st Century Cures Act in December 2016, authorizing $1.8 billion in funding for the Cancer Moonshot over 7 years. The funding must be appropriated each fiscal year (FY) over those 7 years. Congress appropriated $300 million to NCI for FY 2017, $300 million for FY 2018, $400 million for FY 2019, $195 million for FY 2020, and $195 million for FY 2021.
Learn about the progress that has been made in cancer research through the various Cancer Moonshot initiatives.
Implementation teams are considering multiple ways to fund new programs as well as expansions of ongoing efforts to advance the goals of the Cancer Moonshot.
In this seminar series, researchers working across Cancer Moonshot initiatives present on their findings. Additionally, they discuss how their research projects address the Blue Ribbon Panel report’s 10 key recommendations.
New Cancer Moonshot funding opportunities from NCI support goals articulated in the recommendations made by the Blue Ribbon Panel.
A Blue Ribbon Panel of experts was established as a working group of the NCAB to ensure that the Cancer Moonshot's approaches are grounded in the best science. Their report outlines 10 recommendations to accelerate progress against cancer.